Baroset Tablets 10/160/25 mg (Amlodipine Besylate, Valsartan, Chlorthalidone)

Adult dose

This medication should be taken once daily, with one tablet, irrespective of meals, along with water. It is recommended to take it at the same time every day (e.g., in the morning). For patients whose blood pressure is not controlled with the combination therapy of amlodipine/valsartan, administer this medication at 5/80/12.5 mg, and adjust the dose considering the patient's blood pressure response at intervals of more than 2 weeks. The maximum dosage for this medication is 10/160/25 mg.

This medication can cause serious harm to the fetus if taken during pregnancy, especially during the second and third trimesters; therefore, it should be discontinued immediately if pregnancy is confirmed during treatment. Patients with impaired liver function or those with ongoing liver disease should be cautious as this drug can affect the body’s electrolyte balance and lead to hepatic encephalopathy. Patients with severely impaired kidney function should avoid or use this medication cautiously, as some components may accumulate in the body and cause toxicity. Patients with an allergy to this medication's components or similar class drugs, pregnant women, nursing mothers, patients with severe hypotension, and those with severe liver or kidney disorders should not take this medication. Patients with insufficient sodium or fluid should correct their condition before taking this medication, and blood pressure should be closely monitored post-administration due to the possibility of hypotension. Patients with high potassium levels or those taking medications that can increase potassium should frequently monitor potassium levels to ensure there are no abnormalities. Patients with cardiovascular diseases, recent myocardial infarction, or certain heart conditions such as aortic stenosis should use this drug with caution and follow their healthcare provider's instructions. Elderly patients and children require special attention, particularly older adults who are susceptible to electrolyte imbalance or hypotension; it is recommended to start at a lower dose and monitor their condition. During the use of this medication, symptoms such as dizziness, headache, and blood pressure reduction may occur, necessitating caution when driving or operating machinery. There may be interactions with other medications taken concurrently, so it is essential to inform healthcare providers about any other medications being used. In case of overdose, severe hypotension, shock, or altered consciousness may occur, requiring immediate medical attention for proper treatment. This medication should be stored out of the reach of children and kept away from direct sunlight, moisture, and heat.

Serious side effects

Hives, severe swelling (edema), angioedema, chest pain, tightness in the chest, difficulty breathing, vasculitis, toxic epidermal necrolysis, hepatitis, jaundice, intrahepatic cholestasis, abnormal liver function, pulmonary edema, pancreatitis, agranulocytosis, acute kidney failure (interstitial nephritis, etc.), aplastic anemia, thrombocytopenia, leukopenia, severe allergic reactions, severe skin reactions, respiratory issues, liver abnormalities (jaundice), severe neurological symptoms, severe

Mild side effects

Dizziness, headache, increased blood uric acid, increased alanine aminotransferase (ALT), increased aspartate aminotransferase (AST), increased creatine phosphokinase (CPK), increased blood glucose, increased triglycerides (TG), COVID-19, pharyngitis, upper respiratory infection, eyelid twitching, orthostatic hypotension, chest discomfort, vasculitis, weakness, fatigue, pain, weight gain/loss, palpitations, drowsiness, abdominal pain,

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance

Oval film-coated tablets with a deep pink color

Package unit

30 tablets/bottle